HIV蛋白酶抑制剂可提高HIV阴性男性体内脂联素水平。 - Suppr

HIV protease inhibitors increase adiponectin levels in HIV-negative men.

作者信息

Lee Grace A, Mafong Derek D, Noor Mustafa A, Lo Joan C, Mulligan Kathleen, Schwarz Jean-Marc, Schambelan Morris, Grunfeld Carl

出版信息

J Acquir Immune Defic Syndr. 2004 May 1;36(1):645-7. doi: 10.1097/00126334-200405010-00017.

DOI:10.1097/00126334-200405010-00017

PMID:15097312

Abstract

摘要

相似文献

HIV protease inhibitors increase adiponectin levels in HIV-negative men.

J Acquir Immune Defic Syndr. 2004 May 1;36(1):645-7. doi: 10.1097/00126334-200405010-00017.

Mild clinical toxicity and dose-dependent pharmacokinetics following acute lopinavir/ritonavir poisoning in a HIV-positive patient.

AIDS. 2008 Mar 30;22(6):792-3. doi: 10.1097/QAD.0b013e3282f4a0dd.

Effects of lopinavir-ritonavir combined therapy during the rat pregnancy. Morphological and biochemical aspects.

Eur J Obstet Gynecol Reprod Biol. 2007 Jul;133(1):60-3. doi: 10.1016/j.ejogrb.2006.08.004. Epub 2006 Sep 20.

The metabolic effects of lopinavir/ritonavir in HIV-negative men.

AIDS. 2004 Mar 5;18(4):641-9. doi: 10.1097/00002030-200403050-00008.

Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adults.

Eur J Med Res. 2006 Jun 30;11(6):236-44.

The HIV protease inhibitors saquinavir, ritonavir, and nelfinavir but not indinavir impair the epithelial barrier in the human intestinal cell line HT-29/B6.

AIDS. 1999 Dec 24;13(18):2595-7. doi: 10.1097/00002030-199912240-00016.

Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen.

J Antimicrob Chemother. 2004 Aug;54(2):498-502. doi: 10.1093/jac/dkh357. Epub 2004 Jul 14.

Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors.

J Immunol. 2003 Jun 15;170(12):6006-15. doi: 10.4049/jimmunol.170.12.6006.

Once-daily directly observed therapy lopinavir/ritonavir plus indinavir as a protease inhibitor-only salvage therapy in heavily pretreated HIV-1-infected patients: a pilot study.

AIDS. 2006 Jan 2;20(1):129-31. doi: 10.1097/01.aids.0000196174.80798.5b.

Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically.

AIDS. 2006 Sep 11;20(14):1813-21. doi: 10.1097/01.aids.0000244200.11006.55.

引用本文的文献

Vaspin Mediates the Intraorgan Crosstalk Between Heart and Adipose Tissue in Lipoatrophic Mice.

Front Cell Dev Biol. 2021 Sep 24;9:647131. doi: 10.3389/fcell.2021.647131. eCollection 2021.

Bone and fat hormonal crosstalk with antiretroviral initiation.

Bone. 2022 Jan;154:116208. doi: 10.1016/j.bone.2021.116208. Epub 2021 Sep 20.

Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors.

Am J Infect Dis. 2006 Sep 30;2(3):159-166. doi: 10.3844/ajidsp.2006.159.166.

Molecular mechanisms for insulin resistance in treated HIV-infection.

Best Pract Res Clin Endocrinol Metab. 2011 Jun;25(3):459-68. doi: 10.1016/j.beem.2010.10.017.

When to start antiretroviral therapy.

Curr Infect Dis Rep. 2011 Feb;13(1):60-7. doi: 10.1007/s11908-010-0154-8.

Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue.

J Lipid Res. 2011 Feb;52(2):207-20. doi: 10.1194/jlr.M000869. Epub 2010 Nov 10.

HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models.

Curr Opin HIV AIDS. 2008 Nov;3(6):660-5. doi: 10.1097/COH.0b013e3283139134.

No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trial.

Clin Infect Dis. 2008 Aug 15;47(4):567-74. doi: 10.1086/590154.

Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects.

Cardiovasc Toxicol. 2008 Mar;8(1):15-22. doi: 10.1007/s12012-007-9010-y. Epub 2008 Jan 3.

Relationship of fat distribution with adipokines in human immunodeficiency virus infection.

J Clin Endocrinol Metab. 2008 Jan;93(1):216-24. doi: 10.1210/jc.2007-1155. Epub 2007 Oct 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

HIV protease inhibitors increase adiponectin levels in HIV-negative men.

作者信息

Lee Grace A, Mafong Derek D, Noor Mustafa A, Lo Joan C, Mulligan Kathleen, Schwarz Jean-Marc, Schambelan Morris, Grunfeld Carl

出版信息

J Acquir Immune Defic Syndr. 2004 May 1;36(1):645-7. doi: 10.1097/00126334-200405010-00017.

DOI:10.1097/00126334-200405010-00017

PMID:15097312

Abstract

摘要

相似文献

HIV protease inhibitors increase adiponectin levels in HIV-negative men.

J Acquir Immune Defic Syndr. 2004 May 1;36(1):645-7. doi: 10.1097/00126334-200405010-00017.

Mild clinical toxicity and dose-dependent pharmacokinetics following acute lopinavir/ritonavir poisoning in a HIV-positive patient.

AIDS. 2008 Mar 30;22(6):792-3. doi: 10.1097/QAD.0b013e3282f4a0dd.

Effects of lopinavir-ritonavir combined therapy during the rat pregnancy. Morphological and biochemical aspects.

Eur J Obstet Gynecol Reprod Biol. 2007 Jul;133(1):60-3. doi: 10.1016/j.ejogrb.2006.08.004. Epub 2006 Sep 20.

The metabolic effects of lopinavir/ritonavir in HIV-negative men.

AIDS. 2004 Mar 5;18(4):641-9. doi: 10.1097/00002030-200403050-00008.

Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adults.

Eur J Med Res. 2006 Jun 30;11(6):236-44.

The HIV protease inhibitors saquinavir, ritonavir, and nelfinavir but not indinavir impair the epithelial barrier in the human intestinal cell line HT-29/B6.

AIDS. 1999 Dec 24;13(18):2595-7. doi: 10.1097/00002030-199912240-00016.

Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen.

J Antimicrob Chemother. 2004 Aug;54(2):498-502. doi: 10.1093/jac/dkh357. Epub 2004 Jul 14.

Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors.

J Immunol. 2003 Jun 15;170(12):6006-15. doi: 10.4049/jimmunol.170.12.6006.

Once-daily directly observed therapy lopinavir/ritonavir plus indinavir as a protease inhibitor-only salvage therapy in heavily pretreated HIV-1-infected patients: a pilot study.

AIDS. 2006 Jan 2;20(1):129-31. doi: 10.1097/01.aids.0000196174.80798.5b.

Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically.

AIDS. 2006 Sep 11;20(14):1813-21. doi: 10.1097/01.aids.0000244200.11006.55.

引用本文的文献

Vaspin Mediates the Intraorgan Crosstalk Between Heart and Adipose Tissue in Lipoatrophic Mice.

Front Cell Dev Biol. 2021 Sep 24;9:647131. doi: 10.3389/fcell.2021.647131. eCollection 2021.

Bone and fat hormonal crosstalk with antiretroviral initiation.

Bone. 2022 Jan;154:116208. doi: 10.1016/j.bone.2021.116208. Epub 2021 Sep 20.

Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors.

Am J Infect Dis. 2006 Sep 30;2(3):159-166. doi: 10.3844/ajidsp.2006.159.166.

Molecular mechanisms for insulin resistance in treated HIV-infection.

Best Pract Res Clin Endocrinol Metab. 2011 Jun;25(3):459-68. doi: 10.1016/j.beem.2010.10.017.

When to start antiretroviral therapy.

Curr Infect Dis Rep. 2011 Feb;13(1):60-7. doi: 10.1007/s11908-010-0154-8.

Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue.

J Lipid Res. 2011 Feb;52(2):207-20. doi: 10.1194/jlr.M000869. Epub 2010 Nov 10.

HIV protease inhibitors and insulin resistance: lessons from in-vitro, rodent and healthy human volunteer models.

Curr Opin HIV AIDS. 2008 Nov;3(6):660-5. doi: 10.1097/COH.0b013e3283139134.

Clin Infect Dis. 2008 Aug 15;47(4):567-74. doi: 10.1086/590154.

Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects.

Cardiovasc Toxicol. 2008 Mar;8(1):15-22. doi: 10.1007/s12012-007-9010-y. Epub 2008 Jan 3.

Relationship of fat distribution with adipokines in human immunodeficiency virus infection.

J Clin Endocrinol Metab. 2008 Jan;93(1):216-24. doi: 10.1210/jc.2007-1155. Epub 2007 Oct 16.

HIV protease inhibitors increase adiponectin levels in HIV-negative men.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

HIV protease inhibitors increase adiponectin levels in HIV-negative men.

作者信息

出版信息

相似文献

引用本文的文献